Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas E. Hutson
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
Clinical Medicine Insights: Oncology
Oncology
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Rationale for Targeted Therapies and Potential Role of Pazopanib in Advanced Renal Cell Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib
Oncology
Medicine
Cancer Research
Oncology
Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget
Oncology
Real-World Clinical Outcomes of Pazopanib Immediately Following Immunotherapy Discontinuation for the Treatment of Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Clinical Outcome of Third-Line Pazopanib in a Patient With Metastatic Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
Pazopanib Has Equivalent Anti-Tumor Effectiveness and Lower Total Costs Than Sunitinib for Treating Metastatic or Advanced Renal Cell Carcinoma: A Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
